scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.IJROBP.2016.08.003 |
P8608 | Fatcat ID | release_iuknusq47rfx5nfpz3avjssegi |
P932 | PMC publication ID | 5303682 |
P698 | PubMed publication ID | 27727066 |
P50 | author | David I. Rosenthal | Q57015055 |
Quynh-Thu Le | Q89881427 | ||
Adam S Garden | Q90650674 | ||
Randal Weber | Q94950283 | ||
James E Galvin | Q96836608 | ||
Adel K El-Naggar | Q114738475 | ||
Marcie List | Q114738535 | ||
Phuc Felix Nguyen-Tân | Q114738536 | ||
Rita S Axelrod | Q114738537 | ||
Andy M Trotti | Q114738540 | ||
P2093 | author name string | David Schwartz | |
Qiang Zhang | |||
Christopher U Jones | |||
Anurag Singh | |||
George Shenouda | |||
Deborah Bruner | |||
James A Bonner | |||
Minh Tam Truong | |||
Craig Silverman | |||
Eric Sherman | |||
Karen Godette | |||
Chance Matthiesen | |||
André Konski | |||
P2860 | cites work | Human papillomavirus and survival of patients with oropharyngeal cancer. | Q27851567 |
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. | Q34171999 | ||
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure | Q34361336 | ||
US valuation of the EQ-5D health states: development and testing of the D1 valuation model. | Q34396720 | ||
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer | Q36471118 | ||
Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomes | Q36565969 | ||
The development of a Functional Assessment of Cancer Therapy (FACT) questionnaire to assess dermatologic symptoms associated with epidermal growth factor receptor inhibitors (FACT-EGFRI-18). | Q38057970 | ||
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RT | Q39302927 | ||
Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART). | Q39746367 | ||
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients | Q43681440 | ||
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis | Q46732613 | ||
The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. | Q51113959 | ||
A performance status scale for head and neck cancer patients. | Q52866767 | ||
Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. | Q53190270 | ||
Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. | Q53556812 | ||
Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. | Q54141723 | ||
Interpreting clinically significant changes in patient-reported outcomes | Q58876704 | ||
Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer | Q73518553 | ||
Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysis | Q82969960 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cisplatin | Q412415 |
cetuximab | Q420296 | ||
quality of life | Q13100823 | ||
head and neck carcinoma | Q18554836 | ||
phase III clinical trial | Q42824827 | ||
P304 | page(s) | 687-699 | |
P577 | publication date | 2016-08-12 | |
P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
P1476 | title | Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Ra | |
P478 | volume | 97 |
Q39245984 | A systematic literature review of health state utility values in head and neck cancer. |
Q54217162 | Associations among human papillomavirus, inflammation, and fatigue in patients with head and neck cancer. |
Q104285299 | Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis |
Q92180514 | Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer |
Q47437702 | General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival |
Q46326125 | Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial. |
Q91665125 | Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review |
Q42288639 | Prospective observational study of carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck. |
Q88399066 | Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial |
Search more.